In Ioannidis v. Benefit Program for Mass General Brigham and Membership Organization Plan (501), No. 25-12197-FDS, 2026 WL 2874084 (D. Mass. Sept. 24, 2026), District Judge Saylor granted the defendants’ motion to dismiss a former spouse’s ERISA action seeking
Commission targeted consultation on fair access to financial services for cancer survivors
On 29 September 2026, the European Commission (Commission) launched a targeted consultation on fair access to financial services for cancer survivors.
Background
Europe’s beating cancer plan was adopted on 3 February 2021. It is an initiative that aims to tackle
Court Rejects Religious Challenge to Nebraska’s Ban on Midwives Attending Home Births
In Tvrdy v. Hilgers, (D NE, Sept. 26, 2026), a Nebraska federal district court upheld a state law prohibiting certified nurse midwives (CNM) from attending home births without a physician also being present. Midwives may attend births alone only
FinCEN Identifies $17.5 Billion in Suspected Healthcare Fraud, Reinforces Prior Warning to Financial Institutions
On September 9, the U.S. Department of the Treasury announced that the Financial Crimes Enforcement Network (FinCEN) had identified approximately $17.5 billion in suspicious financial activity potentially connected to healthcare fraud. Part of the Treasury Department, FinCEN has primary responsibility
Ohio Legislators Lack Standing to Claim Reproductive Rights Amendment to State Constitution Is Invalid
In Dean v. Yost, (OH Com. Pl., Sept. 22, 2026), two members of the Ohio state legislature and a city council member sued contending that the Reproductive Rights Amendment to the Ohio Constitution adopted by voters in 2023 is
North Dakota Supreme Court Upholds State’s Ban on Gender-Affirming Care for Minors
In T.D. v. Wrigley, (ND Sup. Ct., Sept. 17, 2026), the North Dakota Supreme Court rejected a facial attack on North Dakota’s ban of both hormonal and surgical gender-affirming treatment for minors suffering from gender dysphoria. The court held
FinCEN Identifies $17.5 Billion in Suspected Healthcare Fraud, Reinforces Prior Warning to Financial Institutions
On September 9, the U.S. Department of the Treasury announced that the Financial Crimes Enforcement Network (FinCEN) had identified approximately $17.5 billion in suspicious financial activity potentially connected to healthcare fraud. Part of the Treasury Department, FinCEN has primary responsibility
Supreme Court flags massive cancer drug markups, suggests 16% MRP cap
The Supreme Court on Tuesday questioned the Centre over the wide disparity between the price to retailer (PTR) and Maximum Retail Price (MRP) of cancer drugs and other medicines, asking why there should not be a uniform rule capping the
USPTO Institutes Four IPRs Challenging Janssen’s Golimumab Method-of-Treatment Patents
On September 9, 2026, the U.S. Patent and Trademark Office issued a Notice of Decisions on Institution granting institution in four inter partes review proceedings challenging Janssen Biotech, Inc.’s golimumab method-of-treatment patents: IPR2026-00256, IPR2026-00257, IPR2026-00258, and IPR2026-00259. The notice states,
Vaccination Scenarios, Part 1: Overdue Pets
Let’s face it, approaches to vaccination in companion animals are based partly on direct evidence, partly on extrapolation from other species, partly on expert opinion, and partly on “this is what we do because it’s what we’ve always done.” The